{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:33:11Z","timestamp":1791891191373,"version":"4.3.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2019.00717","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T05:09:58Z","timestamp":1563253798000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Peripheral Blood and Cerebrospinal Fluid Cytokine Levels in Guillain Barr\u00e9 Syndrome: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Ting","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jneuroim.2014.12.017","article-title":"Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyneuropathy","volume":"279","author":"Beppu","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cca.2016.07.013","article-title":"Increased serum concentrations of transforming growth factor-beta1 (TGF-beta1) in patients with Guillain-Barre syndrome","volume":"461","author":"Chang","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.3389\/fimmu.2018.02122","article-title":"Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/jnnp.64.2.162","article-title":"Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barre syndrome: decreased concentrations in the early course and increase with motor function","volume":"64","author":"Creange","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jneuroim.2018.08.001","article-title":"Th17 pathway signatures in a large Indian cohort of Guillain Barre syndrome","volume":"323","author":"Debnath","year":"","journal-title":"J. Neuroimmunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cyto.2018.04.026","article-title":"Comprehensive cytokine profiling provides evidence for a multi-lineage Th response in Guillain Barre Syndrome","volume":"110","author":"Debnath","year":"","journal-title":"Cytokine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/j.1468-1331.2008.02261.x","article-title":"The role of IL-12 and TNF-alpha in AIDP and AMAN","volume":"15","author":"Deng","year":"2008","journal-title":"Eur. J. Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.4049\/jimmunol.1502100","article-title":"Expression of early growth response gene-2 and regulated cytokines correlates with recovery from Guillain-Barre syndrome","volume":"196","author":"Doncel-Perez","year":"2016"},{"key":"B9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12031-018-1100-8","article-title":"Postmortem brain, cerebrospinal fluid, and blood neurotrophic factor levels in Alzheimer's disease: a systematic review and meta-analysis","volume":"65","author":"Du","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.3892\/mmr.2015.3730","article-title":"Toll-like receptor 2 and\u22124 are involved in the pathogenesis of the Guillain-Barre syndrome","volume":"12","author":"Du","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.autrev.2014.01.033","article-title":"Guillain Barre syndrome and other immune mediated neuropathies: diagnosis and classification","volume":"13","author":"Eldar","year":"2014","journal-title":"Autoimmun. Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2147\/NDT.S162896","article-title":"Effect of serum inflammatory markers on the prognosis of adult and pediatric patients with Guillain-Barre syndrome","volume":"14","author":"Ethemoglu","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1136\/jnnp.57.9.1118","article-title":"Tumour necrosis factor-alpha and other cytokines in Guillain-Barre syndrome","volume":"57","author":"Exley","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10875-013-9965-3","article-title":"Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barre syndrome","volume":"34","author":"Han","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1002\/ana.410270716","article-title":"T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barre syndrome","volume":"27","author":"Hartung","year":"1990","journal-title":"Ann. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0165-5728(98)00053-8","article-title":"Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha\/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage","volume":"87","author":"Hohnoki","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1038\/s41598-017-09097-1","article-title":"Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/00207454.2016.1231186","article-title":"Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barre syndrome","volume":"127","author":"Kharwar","year":"2017","journal-title":"Int. J. Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"639712","DOI":"10.1155\/2013\/639712","article-title":"Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barre syndrome","volume":"2013","author":"Li","year":"2013","journal-title":"Mediators Inflamm."},{"key":"B20","doi-asserted-by":"publisher","first-page":"740947","DOI":"10.1155\/2014\/740947","article-title":"Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barre syndrome and downregulated by IVIg","volume":"2014","author":"Li","year":"2014","journal-title":"treatments."},{"key":"B21","doi-asserted-by":"publisher","first-page":"260473","DOI":"10.1155\/2012\/260473","article-title":"IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barre syndrome","volume":"2012","author":"Li","year":"2012","journal-title":"Mediators Inflamm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/ijlh.12845","article-title":"Can we assess severity of Guillain-Barre syndrome using absolute monocyte count?","volume":"40","author":"Li","year":"","journal-title":"Int. J. Lab. Hematol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/00207454.2017.1404465","article-title":"Is serum bilirubin associated with the severity of Guillain-Barre syndrome?","volume":"128","author":"Li","year":"","journal-title":"Int. J. Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3109\/08923973.2012.697469","article-title":"Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barre syndrome","volume":"34","author":"Liang","year":"2012","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1086\/513788","article-title":"The role of cytokines in Schwann cell damage, protection, and repair","volume":"176","author":"Lisak","year":"1997","journal-title":"J. Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"758639","DOI":"10.1155\/2014\/758639","article-title":"Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barre syndrome","volume":"2014","author":"Nyati","year":"2014","journal-title":"Mediators Inflamm."},{"key":"B28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archneurol.2011.51","article-title":"TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome","volume":"68","author":"Nyati","year":"2011","journal-title":"Arch. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1002\/jnr.22514","article-title":"Correlation of matrix metalloproteinases-2 and\u22129 with proinflammatory cytokines in Guillain-Barre syndrome","volume":"88","author":"Nyati","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1046\/j.1468-1331.2000.00005.x","article-title":"Expression of TNFalpha and TGFbeta1 in Guillain-Barre syndrome: correlation of a low TNFalpha-\/TGFbeta1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment","volume":"7","author":"Ossege","year":"2000","journal-title":"Eur. J. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1006\/exnr.2000.7357","article-title":"Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role","volume":"163","author":"Pelidou","year":"2000","journal-title":"Exp. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0165-5728(00)00388-X","article-title":"IL-10 and IFN-gamma in Guillain-Barre syndrome. Network members of the Swedish Epidemiological Study Group","volume":"112","author":"Press","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","article-title":"Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis","volume":"73","author":"Qin","year":"2016","journal-title":"JAMA Neurol."},{"key":"B34","first-page":"216","article-title":"Circulating tumour necrosis factor alpha and soluble TNF receptors in patients with Guillain-Barre syndrome","volume":"117","author":"Radhakrishnan","year":"2003","journal-title":"Indian J. Med. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1034\/j.1600-0404.2003.00179.x","article-title":"Serum tumour necrosis factor-alpha and soluble tumour necrosis factor receptors levels in patients with Guillain-Barre syndrome","volume":"109","author":"Radhakrishnan","year":"2004","journal-title":"Acta Neurol. Scand."},{"key":"B36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cyto.2010.05.005","article-title":"The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barre syndrome from chronic inflammatory demyelinating polyneuropathy","volume":"51","author":"Sainaghi","year":"2010","journal-title":"Cytokine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.410330606","article-title":"Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barre syndrome","volume":"33","author":"Sharief","year":"1993","journal-title":"Ann. Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/BF00868524","article-title":"Potential role of transforming growth factor-beta 1 in terminating the immune response in patients with Guillain-Barre syndrome","volume":"243","author":"Sindern","year":"1996","journal-title":"J. Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000328200","article-title":"Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain-Barre syndrome","volume":"19","author":"Wang","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/brain\/awg207","article-title":"Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndrome","volume":"126","author":"Wanschitz","year":"2003","journal-title":"Brain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fnmol.2018.00236","article-title":"Oxidative stress in Parkinson's disease: a systematic review and meta-analysis","volume":"11","author":"Wei","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1517\/14728222.2016.1086751","article-title":"Are Th17 cells and their cytokines a therapeutic target in Guillain-Barre syndrome?","volume":"20","author":"Wu","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"B45","doi-asserted-by":"publisher","first-page":"21890","DOI":"10.1038\/srep21890","article-title":"Reduced soluble RAGE is associated with disease severity of axonal Guillain-Barre syndrome","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.00717\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T05:10:00Z","timestamp":1563253800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.00717\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":46,"alternative-id":["10.3389\/fnins.2019.00717"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2019.00717","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"article-number":"717"}}